SOLARA
NSESolara Active Pharma Sciences Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹608.55
27.85 (4.80%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.20K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹422+44.2%
52W High₹734.4-17.1%
Current Price
₹608.55
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹486.84
Upper Circuit₹730.26
Reference Price
₹608.55
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹515.0
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹515.0
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
10/20 Bearish Cross detected 5 day(s) ago
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
47%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
553.21
EMA50
528.16
EMA200
542.48
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹612.65
₹645.00
₹655.45
₹665.00
₹711.00
Support (Below)
₹601.15
₹584.38
₹573.88
₹546.50
₹525.00
Volume Analysis
TrendSTABLE
Change-9.50%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Recent MA Crossovers
10/20 Bearish Cross
5 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹602.46
3% Risk₹590.29
5% Risk₹578.12
7% Risk (Custom)
₹565.95Technical Levels
1x ATR (Volatility)₹576.50
2x ATR (Swing)₹544.45
3x ATR (Trend)₹512.40
Immediate Support₹601.15
Moving Averages
EMA 9 (Short-term)₹568.17
EMA 20 (Medium-term)₹553.21
EMA 50 (Trend)₹528.16
EMA 200 (Long-term)₹542.48
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹230.7 Cr | ₹319.2 Cr | ₹313.5 Cr | ₹349 Cr |
| Net Profit | ₹-2.1 Cr | ₹10.5 Cr | ₹-10.1 Cr | ₹-17.4 Cr |
| EPS | — | ₹2.46 | ₹-2.36 | ₹-3.98 |
| Operating Profit | ₹41.7 Cr | ₹58 Cr | ₹35.2 Cr | ₹30.6 Cr |
ROE
0.05%
ROCE
5.59%
Debt/Equity
0.73
Current Ratio
0.77
OPM
8.77%
NPM
-4.99%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 17 Sept 2024 | Annual General Meeting | AGM |
| 15 May 2024 | Rights 1:3 @ Premium Rs 365/- | RIGHTS_ISSUE |
| 08 Sept 2023 | Annual General Meeting | AGM |
| 12 Aug 2022 | Annual General Meeting | AGM |
| 18 Aug 2021 | Annual General Meeting/Dividend - Rs 3 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SOLARA
View All
positive
ET Markets - Industry 17d ago
True North buys 25% stake in pharma co Embio
Private equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will also help scale their contract development and manufacturing business. Embio specializes in complex APIs and synthetic biology.
BFINVESTSOLARASPARCFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 29d ago
Solara Active Pharma spurts after reporting turnaround Q4 perfromance
Solara Active Pharma Sciences soared 15.20% to Rs 584.85 after the company reported consolidated net profit to Rs 9.60 crore in Q4 FY26 compared with net loss of Rs 2.10 crore in Q4 FY25.
SOLARAHealthcare
NEWS
positive
Business Standard - Markets 29d ago
Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter
Sales rise 41.86% to Rs 387.29 crore
SOLARAHealthcare